- Benchmark ASINB0GHV2VH5F
- MarketplaceUS
- Category ID3760901
- Analyzed Products
- Keywordlarge hydrocolloid bandage, hydrocolloid wound dressing, large wound bandage
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-29
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很直接：这个市场不值得进入，且已经进入明显的价格战/高失败区。 你有50万人民币预算，表面上能做单个ASIN的早期启动，但市场里新品牌新上架成功率只有21.43%，新上架里失败占76.32%，而且很多新品牌都是刚进场就亏，说明不是“钱够不够”的问题，而是“进去后能不能活下来”的问题。
从数据看，市场里新品牌只有12个，但新上架产品28个里只跑出6个盈利，22个亏损；更关键的是，近期新产品里真正赚钱的样本很少，2025年到2026年上新的多数都落在低利润或亏损区，说明竞争正在变难，不是变好。能拿来参考的真正赚钱案例并不多：Dodanros 的 B0GHV2VH5F 约 32.65% 利润、月销约 400、月收入约 85.44万；yehooheal 的 B0FP4S6W5D、B0FLD1H6SR、B0FP4T4LQC 也能赚钱；Dexpinzo 的 B0FP4T971C、Vynalia 的 B0G1BPHJ95 也能跑通。可反过来看，失败样本更多：MasterMo 的 B0GJ5XWLFK 利润 -2.75%，Bukihome 的 B0FRSKVYPL、B0G1YQJCNG、B0GFHTZXWM 都没有跑起来；而且 Bukihome 这类新品虽然有 207 次左右评论，但销售并不成立，属于“看起来有热度、实际没跑通”的典型。
对大品牌进入来说，这里不是完全没机会，但需要明显的产品升级、渠道优势或预算更重的打法，直接复制普通铺货不行；可参考的老品牌里，Dimora 仍有多款盈利，像 B08ZJ6BSCR 约 28.87%、B0BNPSCZX2 约 31.42%、B0GGGY8YKZ 约 24.36%，说明老牌在这个类目里仍能吃到利润，属于强势守盘者。对小业务进入来说，更不建议：真正能作为小业务样板的成功新品牌太少，而且一旦要和老品牌、老渠道同场竞争，极容易被压到低利润甚至亏损；如果不做明显差异化、也没有更强投放能力，就不要进。简短说：市场已偏饱和，价格战很重，用户预算虽够启动，但不足以改变胜率；不建议进入。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很明确：这个市场不值得进入。 用户预算500,000 CNY表面上够覆盖单个ASIN的早期铺货、物流和投放，但这个市场已经进入高竞争、低容错状态；新品盈利率只有23.08%，整体盈利率33.33%，而新品牌新品亏损率高达78.57%，说明大多数新入场者都在烧钱却跑不出来。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?28.20%New listing success rate (old brands):27.27%New listing success rate (new brands):21.43%Which new brands have these successful new listings?...Which old brands have these successful new listings?Alternatives- 普通纱布+医用胶带组合：更便宜、药店/便利店更容易买到，适合多数浅表擦伤和轻度渗液伤口；缺点是需要更频繁更换，防水性和“隐形感”较弱。
- 透明防水敷贴（如薄膜敷料）：比大型水胶体通常更容易找到，贴合度高、观察伤口方便，适合低到中度渗出的小面积伤口；但对较明显的渗出吸收能力通常不如水胶体。
- 硅凝胶泡棉/硅胶泡棉敷料：在大面积擦伤、术后表浅伤口上是很实用的替代，通常更温和、拆换时更不易拉扯皮肤；但价格往往更高，且不一定比大号水胶体更“方便”。
- 防粘连无菌敷贴：比大号水胶体更通用，适合清洁后覆盖各种浅表伤口；购买门槛低、尺寸选择多，作为临时替代很常见，但保湿封闭性和减少瘢痕的卖点较弱。
- 液体创可贴/伤口密封剂：对于小裂口、指尖或边缘难贴合部位，使用起来比大号敷料更简单，也不需要裁剪；但不适合渗出较多或面积较大的伤口。
- 自粘弹性绷带+不粘垫片：用于关节、活动部位时更容易在普通药店配齐，覆盖范围灵活，适合应急；但外观、舒适度和持续封闭性通常不如专用大型水胶体。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入，已经明显偏向价格战和高失败率。 关键不是有没有少数高利润样本，而是新品牌整体成功率只有21.43%，新品牌新上架失败率高达78.57%；再看市场利润分布，10%以下的产品很多，且新上架里20%~30%利润的样本虽有，但并不足以抵消整体竞争压力，属于高风险市场。
New products with Highest revenueDodanros
Recent Monthly Revenue (USD):$8,544.00(400pcs/month)B0GHV2VH5F (4.1/5 (63 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableOld brand with the most profitable new productsDimora
Recent Monthly Revenue (USD):$30,260.00(2000pcs/month)B08ZJ6BSCR (4.6/5 (3076 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableRecent Monthly Revenue (USD):$13,050.00(600pcs/month)B0BNPSCZX2 (4.6/5 (3069 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
Recent Monthly Revenue (USD):$12,456.00(600pcs/month)B0GGGY8YKZ (4.4/5 (4 Reviews))Brand is an old entry in this marketNew Upgraded Version on Old ASINSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableMost investment in new productsLeast investment in new productsMasterMo
Recent Monthly Revenue (USD):$397.50(50pcs/month)B0GJ5XWLFK (4.2/5 (57 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%Least profitable new productsBukihome
Recent Monthly Revenue (USD):-(-)B0FRSKVYPL (4.6/5 (207 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (USD):-(-)B0G1YQJCNG (4.6/5 (207 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):-(-)B0GFHTZXWMBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 花瓣形紫色外观很醒目，和常见米色/透明敷料差异大
- |
- 主打关节部位，适合膝盖、肘部等弯折位置
- |
- 超薄防水、可贴7天，适合户外运动和长时间贴附
B0FP4T4LQC (4.1/5 (98 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 透明无色设计，外观和常见敷料明显不同
- |
- 大尺寸透明贴+吸收垫，更偏术后和敏感肌护理
- |
- 硅胶温和粘性，适合老人、敏感肌和易过敏人群
B0GGBHTC2T (4.6/5 (21 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不适合进入，属于高竞争、低容错的价格战市场；对大品牌和小品牌都不是好机会。 新品牌里真正赚钱的只有少数，而且多数新入场产品的利润率仍集中在低位，说明现在更像是靠差异化和品牌势能硬撑，而不是靠普通铺货就能赢。
Profitability difficultyPotential high net profit marginAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B08ZJ6BSCRDimora2021-03-19Yes$15.132000pcs$30260.028.87%$8736.07
B0DPCQ2Z4SFRESINIDER2025-01-17Yes$22.76800pcs$18208.026.99%$4914.34B0BNPSCZX2Dimora2023-03-06Yes$21.75600pcs$13050.031.42%$4100.31
B08F9Y9GBVDimora2020-08-05Yes$16.09700pcs$11263.029.03%$3269.65B0GGGY8YKZDimora2026-04-04Yes$20.76600pcs$12456.024.36%$3034.29B0GHV2VH5FDodanros2026-01-21Yes$21.36400pcs$8544.032.65%$2789.62
B0CPC65BFZFRESINIDER2024-02-29Yes$20.05500pcs$10025.027.14%$2720.79
B09XC9B51MEVERLIT2022-04-07Yes$17.27700pcs$12089.014.6%$1765.0
B0CPC5T96DFRESINIDER2024-03-26Yes$14.99450pcs$6745.523.01%$1552.14
B07Y33R5RLConkote2019-12-20Yes$15.18400pcs$6072.022.09%$1341.31
B08K2YYF6PDr. Med2020-09-25Yes$18.99200pcs$3798.028.44%$1080.16
B0F43VQ8TXCARBOU2025-04-08Yes$18.99200pcs$3798.027.8%$1055.85
B09RVWTSFZNiceful2022-02-06Yes$16.57300pcs$4971.018.04%$896.77
B07QKFX2CLCare Science2018-09-07Yes$9.96700pcs$6972.012.2%$850.59
B0D22SJP6JDWEasyDerm2024-04-18Yes$24.65100pcs$2465.033.28%$820.36
B09V3DG9BLHealqu2022-03-08Yes$22.98100pcs$2298.034.13%$784.31
B07CB6CWCJNexcare2018-03-28Yes$12.35300pcs$3705.019.35%$716.92
B0B9WPCPY1JJ CARE2025-01-01Yes$13.89200pcs$2778.025.37%$704.78
B0FHDQK86QAZEN2025-07-26Yes$18.88200pcs$3776.018.54%$700.08B0BNNB3CHYNiceful2022-11-30Yes$20.42100pcs$2042.033.73%$688.77Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0GGGY8YKZDimora2026-04-04Yes$20.76600pcs$12456.024.36%$3034.29B0GHV2VH5FDodanros2026-01-21Yes$21.36400pcs$8544.032.65%$2789.62B0GGBHTC2TDimora2026-01-12Yes$22.5100pcs$2250.027.33%$614.93
B0G1BPHJ95Vynalia2026-01-27Yes$16.81100pcs$1681.023.74%$399.07B0FP4T4LQCyehooheal2025-08-29Yes$18.2350pcs$911.533.57%$306.0
B0GDDJ54VMPOLYNEW2026-03-31Yes$16.9950pcs$849.520.45%$173.73
B0FP4T971Cyehooheal2025-08-29Yes$8.9100pcs$890.015.49%$137.87
B0FLD1H6SRDexpinzo2025-08-06Yes$9.99100pcs$999.011.9%$118.89
B0FP4S6W5Dyehooheal2025-08-29Yes$10.5650pcs$528.020.77%$109.67#New Product Success Rates
Listing结论很明确：这个市场不适合进入，属于高竞争、接近价格战的市场，新品牌成功率低，且老品牌仍然在强势吃掉利润。 你虽然有50万人民币预算，但这不是核心问题，核心问题是新品牌真实可复制的成功案例太少，且大量新上架产品已经在亏损。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
POLYNEWDimorayehoohealVynaliaDexpinzoDodanrosNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
BukihomeyehoohealGentell SelectOther#Success Rate by Entry Time
Listing这个市场已经进入明显的高竞争/价格战区，不适合继续进入。 2025-2026 的新品牌新增不算“爆量”，但新上架产品里盈利比例只有 23.08%，而非盈利占 78.57%；同时，近期上新的月度表现是“盈利少、失败多”，竞争正在变得更难而不是更容易。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 1 0 0 2 1 1 0 18 2026 0 2 0 0 4 1 0 9 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 1 2025/8 1 0 0 2 1 1 0 8 2025/9 0 0 0 0 0 0 0 8 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 1 2025/12 0 0 0 0 0 0 0 0 2026/1 0 2 0 0 2 1 0 4 2026/2 0 0 0 0 0 0 0 1 2026/3 0 0 0 0 1 0 0 0 2026/4 0 0 0 0 1 0 0 1 2026/5 0 0 0 0 0 0 0 1 2026/6 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases
CVS HealthB07MD1ZHVN (4.6/5 (90 Reviews))CVS Health Advanced Healing Hydrocolloid Bandages (Large Areas)
This listing is deemed profitablePrice (USD)$11.36Released TypeOld Release (2018-12-22)Brand is an old entry in this marketSize and Weight11.5 x 7.3 x 2.2 cm, 9.00gProfitable Factors
Established brand with longevityBased on old ASINDesign & Appearance
大面积大号矩形敷料，偏向覆盖较大伤口区域Key Buying Motive
主打大面积覆盖、吸收少量渗液、长效防水密封，适合水泡和大伤口日常护理Target Customers
需要覆盖脚部水泡、关节摩擦伤或较大局部创面的家庭基础护理用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$1,136.00100 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight15.54% / 17.93%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight14.22% / 16.61%Peak / Non PeakSales & BSR Performance
Care ScienceB07QKFX2CL (4.6/5 (432 Reviews))Care Science Extra Large Hydrocolloid Bandages, 4in x 4in, 3 Count
This listing is deemed profitablePrice (USD)$9.96Released TypeOld Release (2018-09-07)Brand is an old entry in this marketSize and Weight14.0 x 13.7 x 2.1 cm, 45.00gProfitable Factors
Based on old ASINLow pricing strategyDesign & Appearance
淡黄色水胶体敷料，包装采用医疗护理常见的蓝白色系, 4英寸×4英寸的大尺寸方形敷贴，覆盖大面积伤口更直接Key Buying Motive
大面积覆盖、可多日佩戴且具备防水屏障，适合大范围擦伤或水泡护理Target Customers
需要大面积伤口护理、追求省心换药频率更低的家庭急救与日常护理用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$6,972.00700 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight9.09% / 12.20%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight5.81% / 8.91%Peak / Non PeakSales & BSR Performance
Loading samples... 18%